GLP-1 treatment in older adults with kidney disease

Overview

Age alone is not a contraindication, but the risk balance changes. In older adults with CKD the main hazards are muscle loss, dehydration and falls rather than the medicine itself.

Why it's done and who it helps

• Sarcopenia risk rises sharply with rapid weight loss after 70.
• Target a slower rate of loss, often 0.25-0.5 kg per week.
• Protein intake and resistance training become non-negotiable.
• Postural blood pressure should be checked at each review.

Screening for frailty

We assess grip strength, gait speed, falls history and nutritional risk before starting, and repeat during treatment.

Hydration in older adults

Thirst perception declines with age, so dehydration from GLP-1-related nausea can progress to acute kidney injury quickly.

When not to treat

Significant frailty, unintentional prior weight loss, or established protein-energy wasting usually mean the medicine is the wrong tool.

Preparing for your appointment

Is 78 too old?

Not by itself; function and nutritional status matter more than age.

Will I get weaker?

Not if protein and resistance training are in place and progress is monitored.

When to contact your care team

Contact the clinic promptly if you have any of the following:

• Vomiting or diarrhoea lasting more than 24 hours, or you cannot keep fluids down
• Passing much less urine than usual, or new swelling of the legs or face
• Severe pain in the upper abdomen that spreads to your back, with or without vomiting
• A weight change of more than 2 kg in a week that is not explained by fluid
• A missed weekly weight, a missed dose, or any hospital admission

If you are seriously unwell, contact NHS 111 or your renal unit directly rather than waiting for your next review.

Your care at KidneyWeight Clinic

Every dose change, weekly weight and kidney blood test is recorded in your clinical monitoring record, reviewed by Professor Mohammed Mahdi Althaf at six-weekly intervals and formally reassessed at 26 weeks. Booking and your initial payment are handled by professoralthaf.co.uk, medication supply by Healist Pharmacy, and follow-up appointment payments by Carebit.

References

• NICE TA1026: tirzepatide for managing overweight and obesity
• NICE TA875: semaglutide for managing overweight and obesity
• NICE CG189: obesity identification, assessment and management
• NHS: weight-loss medicines

This article is general patient information reviewed by a consultant nephrologist. It is not individual medical advice; treatment decisions are made at a face-to-face consultation.